George Sellers
Stock Analyst at Stephens & Co.
(1.06)
# 3,808
Out of 5,072 analysts
43
Total ratings
27.27%
Success rate
-7.09%
Average return
Main Sectors:
Stocks Rated by George Sellers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ESTA Establishment Labs Holdings | Reiterates: Overweight | $68 | $68.01 | -0.01% | 7 | Aug 7, 2024 | |
| TFX Teleflex | Maintains: Overweight | $275 → $290 | $115.29 | +151.54% | 9 | Aug 2, 2024 | |
| VCEL Vericel | Maintains: Overweight | $56 → $58 | $40.37 | +43.67% | 2 | Aug 2, 2024 | |
| TMDX TransMedics Group | Maintains: Overweight | $151 → $178 | $145.75 | +22.13% | 2 | Aug 2, 2024 | |
| ANIK Anika Therapeutics | Reiterates: Equal-Weight | $24 | $9.78 | +145.40% | 6 | May 29, 2024 | |
| ENOV Enovis | Initiates: Overweight | $72 | $30.31 | +137.55% | 1 | Feb 13, 2024 | |
| APYX Apyx Medical | Maintains: Overweight | $8 → $5 | $4.01 | +24.69% | 2 | Nov 10, 2023 | |
| TMCI Treace Medical Concepts | Reiterates: Equal-Weight | $25 | $3.01 | +730.56% | 4 | Sep 12, 2023 | |
| STAA STAAR Surgical Company | Reiterates: Overweight | $57 | $26.03 | +118.98% | 6 | Aug 14, 2023 | |
| GKOS Glaukos | Reiterates: Overweight | $71 | $105.39 | -32.63% | 4 | May 8, 2023 |
Establishment Labs Holdings
Aug 7, 2024
Reiterates: Overweight
Price Target: $68
Current: $68.01
Upside: -0.01%
Teleflex
Aug 2, 2024
Maintains: Overweight
Price Target: $275 → $290
Current: $115.29
Upside: +151.54%
Vericel
Aug 2, 2024
Maintains: Overweight
Price Target: $56 → $58
Current: $40.37
Upside: +43.67%
TransMedics Group
Aug 2, 2024
Maintains: Overweight
Price Target: $151 → $178
Current: $145.75
Upside: +22.13%
Anika Therapeutics
May 29, 2024
Reiterates: Equal-Weight
Price Target: $24
Current: $9.78
Upside: +145.40%
Enovis
Feb 13, 2024
Initiates: Overweight
Price Target: $72
Current: $30.31
Upside: +137.55%
Apyx Medical
Nov 10, 2023
Maintains: Overweight
Price Target: $8 → $5
Current: $4.01
Upside: +24.69%
Treace Medical Concepts
Sep 12, 2023
Reiterates: Equal-Weight
Price Target: $25
Current: $3.01
Upside: +730.56%
STAAR Surgical Company
Aug 14, 2023
Reiterates: Overweight
Price Target: $57
Current: $26.03
Upside: +118.98%
Glaukos
May 8, 2023
Reiterates: Overweight
Price Target: $71
Current: $105.39
Upside: -32.63%